Bruker Corporation Stock Price and Value Analysis

Should you buy Bruker Corporation stock? (NASDAQ:BRKR). Let's see how it does in our automated value investing analysis system.

  • This company is making money at a modest rate.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is less known than others.

Inside the BRKR Numbers

BRKR Price
(Bruker Corporation stock price per share)
[?] BRKR Fair Price
(based on intrinsic value)
[?] BRKR Safety Price (based on a variable margin of safety) $3.55
[?] PE Ratio versus Sector 213% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Free Cash Flow Jitter 70%
[?] Dividend Yield 0%
Shares Shorted 3,170,213

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,170,213 shares shorted. With 99,815,524 shares available for purchase and an average trading volume over the past 10 trading days of 374,620, it would take at least 8.462 days for all of the short holders to cover their shorts.

Is Bruker Corporation Stock on Sale?

We believe that Bruker Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Bruker Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy BRKR Stock?

Does Bruker Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.